Common Antidepressants Could Have an Unexpected Role in Cancer Survival
8 Articles
8 Articles
Patients who took certain antidepressants were more likely to survive. The cause-and-effect relationship remains to be clarified.
NOVA analysis links taking SSRI antidepressants with lower mortality rates in cancer patients on immunotherapy. The drugs may stimulate the immune system to fight the tumor.
A study compared patients who used antidepressants or benzodiazepines and followed the deaths recorded for two years.
A new large-scale study showed that cancer patients who took common antidepressants in parallel showed higher survival rates during immunotherapy.
Cancer treatment is often long and difficult, and some patients experience severe anxiety and low mood, sometimes leading to depression. An analysis by a Taiwanese research team suggests that selective serotonin reuptake inhibitors (SSRIs), a common antidepressant, may help improve survival rates in cancer patients.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
